Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis

Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis

Hazem Saleh Aljuhani,1,* Rahaf A Hubayni,2,3,* Jumanah Qedair,2,3 Ziad M Bukhari,4 Ahmed Alzahrani,4 Razan Osama Bawazir,2,3 Orjwan Salah Badghaish,2,3 Faisal Alqahtani5 1Ophthalmology Department, Jeddah Eye Hospital, Jeddah, Saudi Arabia; 2College of Medicine, King Saud bin...

Full description

Saved in:
Bibliographic Details
Main Authors: Aljuhani HS, Hubayni RA, Qedair J, Bukhari ZM, Alzahrani A, Bawazir RO, Badghaish OS, Alqahtani F
Format: Article
Language:English
Published: Dove Medical Press 2025-06-01
Series:Clinical Ophthalmology
Subjects:
Neovascular age-related macular degeneration
nAMD
aflibercept
biosimilars
anti-VEGF therapy
efficacy
Online Access:https://www.dovepress.com/efficacy-and-safety-of-aflibercept-biosimilars-relative-to-reference-a-peer-reviewed-fulltext-article-OPTH
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/efficacy-and-safety-of-aflibercept-biosimilars-relative-to-reference-a-peer-reviewed-fulltext-article-OPTH

Similar Items